Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 4c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.87), $0.04 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $131 million versus the consensus estimate of $128.07 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Ionis Pharmaceuticals (IONS) PT Lowered to $125 at H.C. Wainwright
• Piper Sandler lifts Halliburton, Patterson-UTI on stronger U.S. land outlook
• Citi opens 90-day upside catalyst watch on Full Truck Alliance